UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?

Diabetes care, 2016-08, Vol.39 Suppl 2 (Supplement_2), p.S187-S195

2016

Volltextzugriff (PDF)

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

The Lancet (British edition), 2009-06, Vol.373 (9681), p.2125-2135

2009

Volltextzugriff (PDF)

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease

Current cardiology reviews, 2010-05, Vol.6 (2), p.82-90

2010

Volltextzugriff (PDF)

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

The American heart journal, 2013-08, Vol.166 (2), p.240-249.e1

2013

Volltextzugriff (PDF)

Comparison of Multiple Cut Points for Time in Range in Relation to Risk of Abnormal Carotid Intima-Media Thickness and Diabetic Retinopathy

Diabetes care, 2020-08, Vol.43 (8), p.e99-e101

2020

Volltextzugriff (PDF)

Treatment Satisfaction and Quality of Life With Insulin Glargine Plus Insulin Lispro Compared With NPH Insulin Plus Unmodified Human Insulin in Individuals With Type 1 Diabetes

Diabetes care, 2008-06, Vol.31 (6), p.1112-1117

2008

Volltextzugriff (PDF)

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1)

Diabetes care, 2014-10, Vol.37 (10), p.2755-2762

2014

Volltextzugriff (PDF)

Insulin therapy development beyond 100 years

The lancet. Diabetes & endocrinology, 2021-10, Vol.9 (10), p.695-707

2021

Volltextzugriff (PDF)

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents

Diabetes research and clinical practice, 2015-05, Vol.108 (2), p.350-359

2015

Volltextzugriff (PDF)

Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes

Diabetes, metabolic syndrome and obesity, 2011-01, Vol.4 (default), p.23-34

2011

Volltextzugriff (PDF)

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

Diabetes care, 2015-12, Vol.38 (12), p.2217-2225

2015

Volltextzugriff (PDF)

Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: Study design and conduct

The American heart journal, 2013-08, Vol.166 (2), p.208-216.e28

2013

Volltextzugriff (PDF)

Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease

PloS one, 2012-11, Vol.7 (11), p.e49908

2012

Volltextzugriff (PDF)

Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin

Diabetes care, 2014-08, Vol.37 (8), p.2108-2113

2014

Volltextzugriff (PDF)

Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016:39;363-370

Diabetes care, 2017-02, Vol.40 (2), p.e25-e25

Home, Philip D

2017

Volltextzugriff (PDF)

Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters

Diabetes care, 2021-10, Vol.44 (10), p.2212-2215

2021

Volltextzugriff (PDF)

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum

Diabetes care, 2015-08, Vol.38 (8), p.1567-1582

2015

Volltextzugriff (PDF)

Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

The New England journal of medicine, 2007-07, Vol.357 (1), p.28-38

2007

Volltextzugriff (PDF)

Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors' Expert Forum

Diabetes care, 2013-06, Vol.36 (6), p.1779-1788

2013

Volltextzugriff (PDF)

Observational studies: going beyond the boundaries of randomized controlled trials

Diabetes research and clinical practice, 2010-05, Vol.88, p.S3-S9

2010

Volltextzugriff (PDF)

Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics

Diabetes, obesity & metabolism, 2023-03, Vol.25 (3), p.656-663

2023

Volltextzugriff (PDF)

Immune Responses to Insulin Aspart and Biphasic Insulin Aspart in People With Type 1 and Type 2 Diabetes

Diabetes care, 2002-05, Vol.25 (5), p.876-882

2002

Volltextzugriff (PDF)

Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy

The journal of clinical endocrinology and metabolism, 2010-01, Vol.95 (1), p.319-322

2010

Volltextzugriff (PDF)

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

Cardiovascular diabetology, 2009-06, Vol.8 (1), p.27-27

2009

Volltextzugriff (PDF)

Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147

Diabetes care, 2013-07, Vol.36 (7), p.e106-e106

Home, Philip D

2013

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(123)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Humans
(75)
Life Sciences & Biomedicine
(75)
Endocrinology & Metabolism
(55)
Male
(46)
Female
(45)
Diabetes
(42)
Middle Aged
(32)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Adult
(29)
Diabetes Mellitus, Type 2 - Drug Therapy
(27)
Insulin
(27)
Hypoglycemic Agents - Therapeutic Use
(25)
Insulin - Therapeutic Use
(19)
Endocrinopathies
(18)
Diabetes Mellitus
(17)
Diabetes. Impaired Glucose Tolerance
(17)
Endocrine Pancreas. Apud Cells
(17)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease

Results of a reevaluation of cardiovascular outcomes in the RECORD trial

Comparison of Multiple Cut Points for Time in Range in Relation to Risk of Abnormal Carotid Intima-Media Thickness and Diabetic Retinopathy

Treatment Satisfaction and Quality of Life With Insulin Glargine Plus Insulin Lispro Compared With NPH Insulin Plus Unmodified Human Insulin in Individuals With Type 1 Diabetes

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1)

Insulin therapy development beyond 100 years

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents

Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: Study design and conduct

Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease

Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin

Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016:39;363-370

Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum

Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors' Expert Forum

Observational studies: going beyond the boundaries of randomized controlled trials

Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics

Immune Responses to Insulin Aspart and Biphasic Insulin Aspart in People With Type 1 and Type 2 Diabetes

Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147

Suchergebnisse filtern